Report

Japan analytical standards market is predicted to grow at a CAGR of 6.50% between FY2025 and FY2032, rising from USD 72.33 million in FY2024 to USD 119.70 million by FY2032. An extensive healthcare system, significant investment in drug development, expanding pharmaceuticals and biotechnology industries, and raising awareness regarding food safety and environmental monitoring are some factors boosting the growth of Japan analytical standards market. Technological advancement, strict regulations, an ageing population, and growing industrialization lead to a high demand for reliable analytical standards, placing the country for continued expansion.
Government of Japan has imposed strict regulations regarding food safety, which has further increased the demand for analytical standards. Additionally, research institutes and market players combined their efforts to use advanced analytical techniques to maintain food safety standards. The analytical standards market in Japan is growing highly due to economic expansion and technology advancement. Its strong economy promotes high investments in research and development, which results in the invention of advanced analytical instruments and techniques. Technological advancements, especially in analytical instruments such as chromatography and spectroscopy, increase the accuracy and reliability of analytical standards. This has resulted in increased demand for analytical standards in pharmaceuticals, food safety, and environmental monitoring. Therefore, Japan's commitment to innovation and quality ensures high product testing and quality control standards.
Innovative drug development in Japan and considerable government investments in the pharmaceutical sector are greatly enhancing the country's analytical standards market. This commitment to state-of-the-art healthcare requires accurate analytical methods for drug formulations, and therefore, the demand for advanced analytical standards is increasing in this nation, reflecting its commitment to pharmaceutical excellence. For instance, in July 2024, the Japanese government launched a 'drug discovery land' roadmap until 2028 to strengthen its position in the global biopharmaceutical market. The plan focuses on increase of clinical trial facilities, expansion of venture capital and investments of global pharmaceutical companies, as well as private funding & investment in drug discovery start-ups. Moreover, in FY2022, Japanese government in collaboration with The Ministry of Economy, Trade and Industry (METI) introduced 'the Startup Development Five-Year Plan' to increase startup investment tenfold by 2027. Through this initiative, in January 2024, METI launched Japan Innovation Campus in Silicon Valley to encourage private-public collaborations and investments. Thus, rising number of start-ups in the biopharma field will further increase the demand for various analytical systems; supporting the market growth in the country.
Expanding Pharmaceuticals and Biotechnology Industries Impacting Japan Analytical Standards Market
The growth of pharmaceutical and biotech companies in Japan and the increase in their manufacturing facilities is significantly boosting the country's analytical standards market. With these companies increasing production to meet global demands, accurate and reliable analytical methods are needed. Advanced analytical standards are required to maintain quality control and regulatory compliance, creating demand for high-precision testing tools and methodologies. This expansion reflects the broader growth and innovation within Japan's pharmaceutical sector, reinforcing the importance of stringent analytical standards to support developing and manufacturing high-quality pharmaceuticals and biotechnology products. As a result, the analytical standards market is booming with the dynamic growth of Japan's pharmaceutical and biotech industries.
For instance, in January 2024, AGC Biologics S.p.A., expanding from its Chiba site, established a new Yokohama facility to expand preclinical and commercial production of protein biologics, cell therapies, and mRNA therapies. This expansion caters to the high regional demand for quality biopharmaceutical partners, thus raising the need for advanced analytical standards in Japan.
Rising Concern for Food Safety
The growing awareness of food safety in Japan bolsters the growth of the analytical standards market. As public awareness increases and the regulatory framework becomes more stringent, there is a need for accurate testing techniques to identify contaminants and ensure the quality of food. Hence, the demand for sophisticated analytical standards has increased, which supports the advancement of techniques like chromatography and mass spectrometry. These techniques are critical to maintaining high food safety standards and meeting regulatory compliance. This trend is underpinned by the need for good analytical standards to protect public health and ensure food safety, thereby significantly boosting the analytical standards market in Japan. On 7th June, World Food Safety Day highlights the significance of safe food for health and prosperity. The Japan International Research Center for Agricultural Sciences (JIRCAS) actively advocates food safety awareness through campaigns such as education programs and collaborations with international organizations. Japan recently implemented the "Strategy MIDORI" on sustainable food systems, again emphasizing food safety. Public awareness in Japan is on the rise, and better analytical standards are needed to ensure the quality and safety of food.
The Pharmaceutical & Life Sciences Segment holds a Major Market Share of the Analytical Standards Market
The pharmaceutical and life sciences segment has the highest market share in Japanese analytical standards. This is primarily because of the very stringent requirement for accuracy and reliability. This sector also increases with the need for high-quality testing for maintaining strict regulatory compliance. Advanced analytical standards are significant in verifying new drug formulations, as well as product consistency. International standards need to be maintained as well. Moreover, the emphasis on new drug development and biotechnology increases the need for advanced analytical techniques. With an increase in manufacturing facilities and new therapies, the importance of strong analytical testing is also increasing. Thus, the above dependency of this segment to deliver its results based on correct analytical standards only increases its market leadership.
For instance, in September 2024, Shimadzu Corporation invested in Sepragen Corporation, known for its purification chromatography equipment. This investment enabled Shimadzu to sell and service Sepragen's products exclusively in Japan, Korea, and Southeast Asia, thereby enhancing the biopharmaceutical manufacturing process. This step highlights the substantial share of the Pharmaceutical & Life Sciences segment in Japan's analytical standards market because of the demand for advanced purification and testing methods.
Future Market Scenario (FY2025-FY2032F)
Several factors are expected to drive the analytical standards market in Japan in the future. Public awareness about safety of food, stringent regulatory expectations, and advancements in pharmaceutical as well as biotechnology are the major drivers. They require accurate testing techniques and standard quality for compliance and overall product quality. Government policies stimulating innovation and higher R&D investments further drive market, displaying Japan's interest in staying ahead with high standards.
For instance, in July 2024, Japan Association for Cellular Agriculture (JACA), a non-profit think tank, published an in-depth report in the global safety assessment and regulatory trends on cultured food. This report offers valuable insights to the cultivated food industry in Japan, emphasizing critical safety considerations. JACA aims to build consensus on necessary measures for cellular agriculture companies regulated in Japan. This increasing demand on food safety is likely to drive the growth of the analytical standards market for the years ahead in Japan.
Key Players Landscape and Outlook
Major players in Japan's analytical standards market are highly investing in new product development to enhance the quality of new drugs and biotechnological products. Their approach includes new product introduction and facilities expansion as they expand their manufacturing volume, which leads to further growth in the market with high standards for pharmaceutical and biotechnology industries.
In November 2024, Agilent Technologies Inc., the Japanese subsidiary of the US-based Agilent Technologies, launched a new liquid chromatograph. The new product automates several analytical tasks, thus helping reduce the workload of researchers. The product is designed for use in pharmaceutical and food industries, academia, and CDMOs. By boosting the efficiency of operations, this launch further consolidates Agilent's market leadership and demonstrates its commitment to cutting-edge technological solutions.